Middle East & Africa Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale, Application, Technology, and End User

List of Tables

The Middle East & Africa bioreactors market was valued at US$ 194.58 million in 2022 and is expected to reach US$ 292.40 million by 2030; it is estimated to record a CAGR of 5.2% from 2022 to 2030.

Increasing Adoption of Single-Use Bioreactors Bolsters Middle East & Africa Bioreactors Market

Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.

Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.

The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.

Middle East & Africa Bioreactors Market Overview

In Saudi Arabia, the bioreactors market is driven by a rising number of startup companies and increasing awareness about research and developments happening in the country for the enhancement of research activities. Research and technology are significantly governed by an increasing number of research projects undertaken by institutes such as King Abdullah University of Science and Technology. Well-developed research centers focus on increasing research studies for the treatment of various diseases, which in turn would increase the development of new treatment methods and hence also fuel the market growth. For instance, a study, "Chimeric antigen receptor structure and manufacturing of clinical grade CAR engineered cells using different bioreactors," was conducted in 2022 under the Stem Cell & Tissue Re-engineering Program in King Faisal Specialist Hospital & Research Centre, Kingdom of Saudi Arabia.

In Saudi Arabia, government initiatives are responsible for private sector involvement in healthcare expansion and investment. The developed healthcare expenditure and increasing government initiatives in Saudi Arabia are influencing the growth of the bioreactors market.

Middle East & Africa Bioreactors Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Bioreactors Market Segmentation

The Middle East & Africa bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the Middle East & Africa bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.

In terms of application, the Middle East & Africa bioreactors market is categorized into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.

By technology, the Middle East & Africa bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.

Based on end user, the Middle East & Africa bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.

Based on country, the Middle East & Africa bioreactors market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioreactors market share in 2022.

Applikon Biotechnology BV, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the Middle East & Africa bioreactors market.

Product Code: BMIRE00030245

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Bioreactors Market - Key Industry Dynamics

4.1 Bioreactors Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Adoption of Single-Use Bioreactors
- 4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
- 4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
- 4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
- 4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:

5. Bioreactors Market - Middle East & Africa Market Analysis

5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 - 2030

6. Middle East & Africa Bioreactors Market Analysis - Scale

6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
- 6.3.1 Overview
- 6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
- 6.4.1 Overview
- 6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
- 6.5.1 Overview
- 6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Bioreactors Market Analysis - Application

7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
- 7.3.1 Overview
- 7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
- 7.4.1 Overview
- 7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Bioreactors Market Analysis - Technology

8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
- 8.3.1 Overview
- 8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
- 8.4.1 Overview
- 8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Bioreactors Market Analysis - End User

9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
- 9.3.1 Overview
- 9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
- 9.4.1 Overview
- 9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
- 9.5.1 Overview
- 9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Bioreactors Market - by Country Analysis

10.1 Middle East & Africa Bioreactors Market
- 10.1.1 Middle East & Africa Bioreactors Market Revenue and Forecasts and Analysis - By Country
  - 10.1.1.1 Saudi Arabia
  - 10.1.1.2 Overview
  - 10.1.1.3 Saudi Arabia: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.4 Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
    - 10.1.1.4.1 Saudi Arabia Bioreactors Market Breakdown by Scale
    - 10.1.1.4.2 Saudi Arabia Bioreactors Market Breakdown by Application
    - 10.1.1.4.3 Saudi Arabia Bioreactors Market Breakdown by Technology
    - 10.1.1.4.4 Saudi Arabia Bioreactors Market Breakdown by End User
  - 10.1.1.5 South Africa
  - 10.1.1.6 Overview
  - 10.1.1.7 South Africa: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.7.1 South Africa Bioreactors Market Breakdown by Scale
    - 10.1.1.7.2 South Africa Bioreactors Market Breakdown by Application
    - 10.1.1.7.3 South Africa Bioreactors Market Breakdown by Technology
    - 10.1.1.7.4 South Africa Bioreactors Market Breakdown by End User
  - 10.1.1.8 UAE
  - 10.1.1.9 Overview
  - 10.1.1.10 United Arab Emirates: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.10.1 United Arab Emirates Bioreactors Market Breakdown by Scale
    - 10.1.1.10.2 United Arab Emirates Bioreactors Market Breakdown by Application
    - 10.1.1.10.3 United Arab Emirates Bioreactors Market Breakdown by Technology
    - 10.1.1.10.4 United Arab Emirates Bioreactors Market Breakdown by End User
  - 10.1.1.11 Rest of Middle East & Africa
  - 10.1.1.12 Overview
  - 10.1.1.13 Rest of Middle East & Africa: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.13.1 Rest of Middle East & Africa Bioreactors Market Breakdown by Scale
    - 10.1.1.13.2 Rest of Middle East & Africa Bioreactors Market Breakdown by Application
    - 10.1.1.13.3 Rest of Middle East & Africa Bioreactors Market Breakdown by Technology
    - 10.1.1.13.4 Rest of Middle East & Africa Bioreactors Market Breakdown by End User

11. Bioreactors Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 PBS Biotech Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 General Electric Co
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Merck KGaA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sartorius AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pall Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Solaris Biotechnology SRL
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms